post-add

Articles for Oncology

Role Of Pain Management Solutions In Oncology

It is estimated that less than 3 per cent of India's cancer patients have access to adequate pain relief

Read More
Precision Redefined: Transforming Neurosurgery In South Asia

In India, the burden is notably high, with about 1.2 million new cases and 930,000 deaths in 2019, making it a major contributor to cancer in Asia

Read More
How Comprehensive Genomic Profiling Is Reshaping Cancer Patient Management

According to the Global Cancer Observatory (GLOBOCAN), in 2022, India recorded 1.41 million new cancer cases, placing it third globally after China and the United States of America

Read More
Lip-Bu Tan Joins 4baseCare’s Advisory Board To Propel Growth In Precision Oncology

Beyond his roles at Walden International and Walden Catalyst Ventures, he is the anchor investor and advisor at Yali Capital, the venture fund that spearheaded 4baseCare's USD 6 million Series A funding round

Read More
HealthCare Global Enterprises Reports Strong Q1 FY25 Results With 14 Per Cent Revenue Growth

The revenue increased from Rs 4,607 million in Q1 FY24 to Rs 5,256 million in Q1 FY25

Read More
Importance Of Radiation During Treatment Of Breast Cancer

Among the various treatment modalities available, radiation therapy plays a crucial role in the comprehensive management of breast cancer

Read More
Sahyadri Hospitals Introduces Asia’s First Radixact X9 System With VitalHold Technology

A standout feature of the Radixact X9 is the Auto Beam Hold, which pauses radiation delivery if the patient moves beyond the tolerance limit during treatment, enhancing both safety and precision

Read More
Surgery At Sir Ganga Ram Hospital Removes Rare, Life-Threatening Rhabdomyoma Tumor

The MRI revealed a large tumour, approximately 9-10 cm in size, exerting pressure on the posterior aspect of the nose, windpipe, and foodpipe

Read More
Zydus Secures COFEPRIS Approval For Mamitra, Trastuzumab Biosimilar To Combat Multiple Cancers

This new approval allows Mamitra to be marketed in strengths of 150 mg and 440 mg, targeting HER2 overexpressing metastatic breast cancer (MBC), HER2 overexpressing early breast cancer (EBC), and advanced gastric cancer

Read More
Francis deSouza Joins 4baseCare Advisory Board, Enhancing Precision Oncology Expertise

deSouza, a Silicon Valley tech veteran and former CEO of Illumina brings over 30 years of leadership experience in genomics, technology, and healthcare

Read More

Subscribe to our newsletter to get updates on our latest news